New Providence Acquisition Corp. III logo

NPAC

NASDAQ

New Providence Acquisition Corp. III

$10.56+0.04 (+0.38%)

New Providence Acquisition Corp. III (NPAC) is a Blank Checks company listed on NASDAQ. There were no new wire items for NPAC in the last 30 days. The most recent was published Aug 14, 2026.

Price$10.56+0.14 (+1.34%)
2026-07-302026-10-30
News · 26 weeks60%
2026-05-10: 12026-05-17: 02026-05-24: 02026-05-31: 02026-06-07: 22026-06-14: 02026-06-21: 02026-06-28: 02026-07-05: 02026-07-12: 02026-07-19: 02026-07-26: 02026-08-02: 12026-08-09: 22026-08-16: 02026-08-23: 02026-08-30: 02026-09-06: 02026-09-13: 02026-09-20: 02026-09-27: 02026-10-04: 02026-10-11: 02026-10-18: 02026-10-25: 02026-11-01: 0
2026-05-102026-11-01
Mix390d
  • SEC Filings2(67%)
  • Other1(33%)

Latest news

25 items

NPAC FAQ

6 questions
  • What is the latest news on NPAC?
    Quantisnow has not tracked any new filings, ratings or press releases for NPAC in the last 30 days. The most recent wire item was published on August 14, 2026.
  • Where does NPAC stock trade?
    New Providence Acquisition Corp. III (NPAC) is listed on NASDAQ.
  • What sector and industry is NPAC in?
    New Providence Acquisition Corp. III operates in the Finance sector, Blank Checks industry.
  • When did New Providence Acquisition Corp. III go public?
    New Providence Acquisition Corp. III (NPAC) completed its IPO in 2025.
  • What companies are similar to NPAC?
    Notable peers in the same industry include CVII (Churchill Capital Corp VII), JWSM (Jaws Mustang Acquisition Corp.), HERA (FTAC Hera Acquisition Corp.), CPUH (Compute Health Acquisition Corp.), CONX (CONX Corp.). Compare NPAC side-by-side with any of them on Quantisnow.
  • How can I track NPAC on Quantisnow?
    Quantisnow aggregates New Providence Acquisition Corp. III's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NPAC to receive live email and push alerts on every new disclosure.